Twice-a-year injected drug shows promise for first-line HIV treatment
Novel, twice-a-year injected drug suppresses multidrug-resistant HIV in most patients on failing therapy
Top 5 stories on injectable HIV treatment and prevention from CROI 2021
Every-other-month injectable cabotegravir and rilpivirine suppresses viral load for two years
HIV capsid inhibitor offers new option for people with highly resistant HIV
Antibody-based PrEP did not stop most types of HIV – but is still hailed as a ‘game changer’
Anthony Fauci: “I don’t do this because I’m a hero. I do it because it’s necessary.”
Long-acting injectables appear feasible for long-term HIV treatment
Could a multiple sclerosis medication be used against the HIV reservoir?
